Hi Dr. G***h, I’m J***e, an HR Recruiter at StrategyBrain. I came across your impressive tenure as CEO & President of R***s M***s and your track record building high-impact biotech ventures. We’re partnering with E***e T***s,a Series A immuno-oncology and precision medicine startup,to find their next CEO & Chairman of the Board. Given your experience in leading corporate strategy, R&D and clinical operations, I believe this role could be a strong match. Would you be open to a brief conversation to explore the opportunity?

Hi M***k, Great to hear you’re intrigued by E***e’s platform. Here’s a closer look at the CEO & Chairman role and why your experience would be a powerful fit: 1. Strategic Leadership & Impact • You’ll set and execute corporate strategy to advance our immuno-oncology and precision medicine pipeline from discovery through proof-of-concept. • As a company of ~50 scientists and clinicians, your guidance will directly shape our culture, governance and R&D priorities. 2. Operational Oversight • You’ll oversee R&D, clinical operations and regulatory affairs,areas where you’ve driven R***s M***s into late-stage trials. • You’ll ensure clear milestones and deliverables, leveraging your track record in translational research and trial design. 3. Partnership & Funding • You’ll cultivate strategic alliances with venture investors, academic centers and industry collaborators,a natural extension of your T***k and C***n experience. • You’ll lead fundraising rounds and investor communications as our primary board liaison. 4. Team Building & Talent Development • You’ll recruit, mentor and align a high-performing executive team across science, operations, finance and commercial functions. • Your leadership will accelerate our growth from Series A into a scalable enterprise. 5. Growth & Rewards • Competitive base salary plus equity and performance bonus structure. • Significant upside as an early leader in a fast-moving immuno-oncology startup. E***e offers you the chance to leverage your history of building and scaling biotech ventures, while owning the CEO & Chair seat at a truly nimble, innovation-first company. Does this overview resonate? I’d be happy to dive deeper on any point or discuss next steps. If you’d like to connect live, would Tuesday at 10:00 am PT or Wednesday at 2:00 pm PT work for a 30-minute call? Let me know your preference or other availability. Looking forward to your thoughts. Best, J***e HR Recruiter, StrategyBrain

Hi M***k, Absolutely,happy to share more color: • Target Equity: For a Series A CEO & Chair role at E***e, we’re looking at a mid-single-digit percentage of fully diluted equity (typically in the 3,6% range), coupled with a performance bonus plan and competitive base. We can dive deeper into the structure and vesting schedule on our call. • On-Site Expectations: E***e’s HQ is in the San Francisco Bay Area. We expect our CEO to be on-site roughly 3,4 days per week,immersed with the science and leadership teams,while allowing flexibility for travel to investors, conferences, or partner sites. Tuesday at 10:00 am PT works perfectly. I’ll send a calendar invite with dial-in details shortly. Please let me know if you have any other questions beforehand. Looking forward to our conversation! Best, J***e HR Recruiter, StrategyBrain

Hi M***k, Sure thing,here’s a high-level on both: 1. Base Salary • We’re targeting a competitive annual base in the $350K,450K range, depending on final scope and your experience. • On top of that, there’s a performance-based bonus (typically 25,30% of base) and standard executive benefits. 2. Planned Board Composition • You’ll serve as Chair alongside a tight, five-member board: , Two investor directors (lead Series A and a syndicate partner) , One independent scientific advisor with deep immuno-oncology expertise , Our co-founder/CSO (to ensure seamless R&D alignment) • This mix is designed to balance investor oversight, scientific rigor and operational leadership. Happy to dive into more detail on Tuesday at 10:00 am PT. Let me know if anything else comes up in the meantime! Best, J***e

Hi M***k, Happy to share more detail: • Lead Series A Investor Director , The lead investor is a Partner at the biotech-focused firm that spearheaded E***e’s Series A. They bring deep immuno-oncology expertise and a strong track record of scaling early-stage companies, and they hold one of the two investor seats on our board. • Board Meeting Cadence , Quarterly full-board meetings (typically 2,3 hours, held at our Bay Area HQ or via video). , Monthly written board updates (financials, key milestones, risks). , Ad hoc calls or deep-dives between meetings for critical milestones (e.g., trial initiations, data readouts, fundraising checkpoints). Let me know if you’d like any further color ahead of our Tuesday 10:00 am PT call. Looking forward to it! Best, J***e HR Recruiter, StrategyBrain